Programme
Programme
Day 1
08:30 — 09:00
Registration and welcome coffee
09:00 — 09:15
Welcome and opening remarks
Introduction by ASI director and overview of objectives
09:15 — 10:15
Keynote lecture 1 - Precision medicine - Transforming oncology
The tumour microenvironment's myeloid gatekeepers: Mechanisms and therapeutic targeting of MDSCs in cancer immunotherapy
10:15 — 10:45
Coffee break and poster session
10:45 — 11:45
Breakout session 1: Computational oncology and AI: Deciphering cancer's code
Harnessing synthetic lethality and AI for next-generation precision oncology
11:45 — 12:45
Panel discussion: Challenges in translating genomics into clinical practice
Genomic and metabolic landscapes of gliomas: Uncovering vulnerabilities through IDH mutations
12:45 — 14:00
Lunch and poster session
14:00 — 14:30
Breakout session 2: Molecular mechanisms and novel therapeutic avenues
Targeting protein prenylation and Icmt: A novel strategy to induce autophagy and cancer cell death
14:30 — 16:00
Workshop 1
Single-cell and spatial transcriptomics approaches to unravel melanoma heterogeneity and microenvironment interactions
16:00 — 16:30
Coffee break and poster session
16:30 — 18:00
Panel: The future of foundational cancer research: Integrating omics and AI
Day 2
08:30 — 09:00
Welcome coffee
09:00 — 09:15
Daily welcome and announcements
Recap of day 1 and overview of day 2
09:15 — 10:15
Keynote lecture 2: Translational bridges
Circulating tumour DNA for molecular residual disease detection in NSCLC: From bench to bedside and beyond
10:15 — 10:45
Coffee break and poster session
10:45 — 11:45
Breakout session 3: Advanced biomarkers and early detection strategies
Navigating therapeutic resistance in EGFR/ALK NSCLC: Biomarkers and novel strategies
11:45 — 12:45
Innovations in diagnosing and targeting leptomeningeal metastases: Breaching the CSF barrier
Novel biomarkers for Asian-prevalent cancers or liquid biopsy advancements in Hong Kong
12:45 — 14:00
Lunch and poster session
14:00 — 15:00
Breakout session 4: The tumour microenvironment: A double-edged sword
Targeting specific myeloid subsets to overcome immunotherapy resistance
15:00 — 16:00
Metabolic crosstalk and immune modulation in the glioma microenvironment
16:00 — 16:30
Coffee break and poster session
16:30 — 18:00
Workshop: Navigating clinical trial design in the era of precision medicine
Day 3
08:30 — 09:00
Welcome coffee
09:00 — 09:15
Daily welcome and announcements
Recap of day 2 and overview of day 3
09:15 — 10:15
Breakout session 5: Novel therapeutic modalities and clinical trials
Antibody-drug conjugates: Expanding the precision oncology toolkit/ Cellular therapies: Clinical progress and future challenges
10:15 — 10:45
Coffee break and poster session
10:45 — 12:45
Breakout session 6: Overcoming challenges and future horizons in precision oncology
Integrating multi-omics data for personalised cancer therapy: Challenges and opportunities
12:45 — 14:00
Lunch break and poster session
14:00 — 15:00
Panel discussion: Bridging the Gap – Accelerating translation from bench to bedside
15:00 — 15:30
The future of global collaboration in precision oncology: An Asia-Pacific perspective
15:30 — 16:00
Closing ceremony
Summarising key takeaways and outlining steps to sustain collaborative efforts
Stay in the loop!
Subscribe to keep up with the latest from Croucher Foundation.